Fundz

Rubius Therapeutics, Inc. reported raising $115 Million in an initial SEC Form D filing, from an offering of $120 Million

PRIVATEJun 22, 2017$115M of $120M raised

Amount Raised

$115 Million

$115 Million sold, per SEC Form D (first sale Jun 22, 2017)

Round Type

Venture

CambridgeBiotechnology

Quick answer

Rubius Therapeutics, Inc. raised $115 Million in a funding round, dated June 22, 2017. Rubius Therapeutics, Inc. is based in Cambridge, Massachusetts, United States.

How much did Rubius Therapeutics, Inc. raise?
Rubius Therapeutics, Inc. raised $115 Million in a funding round on June 22, 2017.
What does Rubius Therapeutics, Inc. do?
Rubius is developing a new class of drugs, Red-Cell Therapeutics™,
Where is Rubius Therapeutics, Inc. based and how big is it?
Rubius Therapeutics, Inc. is based in Cambridge, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Rubius Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • UbiVac raised $200K (Pre-Seed) on August 4, 2017.
  • OXOS Medical raised $150K (Seed) on August 4, 2017.
  • ALAMAB THERAPEUTICS INC. raised $12M on August 4, 2017.
  • Amylyx Pharmaceuticals raised $1.8M (Seed) on August 4, 2017.
  • Poseida Therapeutics, Inc. raised $11M on August 3, 2017.
  • NeuroOne Medical Technologies Corporation raised an undisclosed amount on August 2, 2017.

Who to call at Rubius Therapeutics, Inc., and when

A new round usually means Rubius Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rubius Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rubius Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rubius Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rubius Therapeutics, Inc.

Location

325 VASSAR STREET, SUITE 1A

Cambridge, Massachusetts, United States

About

Rubius is developing a new class of drugs, Red-Cell Therapeutics™,

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rubius Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Rubius Therapeutics, Inc.'s next move

See what Strategic adds

Rubius Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.